GenMark Diagnostics, Inc. elected Stephen Worland, Ph.D. as director to serve a three-year term expiring at GenMark's 2016 Annual Meeting of Stockholders.
GenMark Diagnostics, Inc.
Equities
GNMK
US3723091043
Advanced Medical Equipment & Technology
1st Jan change | Capi. | |
---|---|---|
+7.23% | 217B | |
+11.31% | 191B | |
+28.94% | 154B | |
+32.00% | 112B | |
-0.46% | 62.84B | |
+16.09% | 53.34B | |
+0.94% | 48.83B | |
-2.97% | 39.36B | |
+1.23% | 35.73B |